Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

CureVac N.V. Ordinary Shares (CVAC)

https://www.curevac.com

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/14/2020

Market Cap

733,480,620

Shares Outstanding

223,880,000

Weighted SO

223,923,708

Total Employees

N/A

Upcoming Earnings

08/15/2024

Similar Tickers

Beta

2.6370

Last Div

0.0000

Range

2.215-9.56

Chg

0.0200

Avg Vol

1336970

Mkt Cap

733480620

Exch

NASDAQ

Country

DE

Phone

49 7071 9883 0

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

11.3960

EV Multiple

-1.6500

P/FV

1.4896

Div Yield %

0.0000

P/E

-2.4559

PEG

-0.0684

Payout

0.0000

Current Ratio

2.2502

Quick Ratio

2.0942

Cash Ratio

1.7873

DSO

238.2376

DIO

63.1027

Op Cycle

301.3402

DPO

44.4418

CCC

256.8985

Gross Margin

-1.5947

Op Margin

-4.9562

Pretax Margin

-4.6252

Net Margin

-4.6399

Eff Tax Rate

-0.0032

ROA

-0.3926

ROE

-0.4894

ROCE

-0.5542

NI/EBT

1.0032

EBT/EBIT

0.9332

EBIT/Rev

-4.9562

Debt Ratio

0.0589

D/E

0.0909

LT Debt/Cap

0.0737

Total Debt/Cap

0.0834

Int Coverage

-153.8551

CF/Debt

-6.4273

Equity Multi

1.5449

Rec Turnover

1.5321

Pay Turnover

8.2130

Inv Turnover

5.7842

FA Turnover

0.2094

Asset Turnover

0.0846

OCF/Share

-1.1646

FCF/Share

-1.3710

Cash/Share

1.3552

OCF/Sales

-4.4710

FCF/OCF

1.1772

CF Coverage

-6.4273

ST Coverage

-51.3384

CapEx Coverage

-5.6420

Div&CapEx Cov

-5.6420

P/BV

1.4896

P/B

1.4896

P/S

11.3960

P/E

-2.4559

P/FCF

-2.1651

P/OCF

-2.5487

P/CF

-2.5487

PEG

-0.0684

P/S

11.3960

EV Multiple

-1.6500

P/FV

1.4896

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Aug 27, 02:48 Simtra BioPharma Solutions ernennt Dr. Lidia Serina zum Head of Development Services Benzinga Dec 19, 13:34 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Revenue Product Segmentation